The value of measuring percent high-density lipoprotein in assessing risk of cardiovascular disease
- 1 March 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 142 (3), 469-472
- https://doi.org/10.1001/archinte.142.3.469
Abstract
The measurement of high density lipoprotein (HDL) for the purpose of assessing the risk of cardiovascular disease in the individual subject was evaluated. Three laboratory methods were compared, 2 electrophoretic and 1 heparin-manganese precipitation, and the HDL results were expressed both as a percent and as an absolute concentration. In phase 1 of the study, the optimal method and the best cut point were identified. In phase 2, these were applied to a larger population who were assigned, on the basis of clinical criteria, to a coronary heart disease and to a control group. The overall probability of correct classification of an individual by his HDL result was calculated. When HDL was expressed as a percent and determined by gel electrophoresis, 82.6% of control subjects and 83.0% of patients with coronary heart disease were classified correctly using the optimal cut point of 23.5%.This publication has 10 references indexed in Scilit:
- ALPHA LIPOPROTEIN (HDL) CHOLESTEROL IN THE SERUM AND THE RISK OF CORONARY HEART DISEASE AND DEATHThe Lancet, 1980
- Decreased HDL cholesterol in prepubertal and pubertal children of CHD patientsAtherosclerosis, 1980
- Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium.Clinical Chemistry, 1979
- Enzymic determination of cholesterol in serum lipoproteins separated by electrophoresis.Clinical Chemistry, 1978
- NORMAL SERUM-CHOLESTEROL BUT LOW H.D.L.-CHOLESTEROL CONCENTRATION IN YOUNG PATIENTS WITH ISCHÆMIC CEREBROVASCULAR DISEASEThe Lancet, 1978
- Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel.Clinical Chemistry, 1977
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- THE TROMSØHEART-STUDYThe Lancet, 1977
- A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESSThe Lancet, 1976